Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127890301 | 12789030 | 1 | I | 20160923 | 20160923 | 20160928 | 20160928 | PER | US-PFIZER INC-2016451212 | PFIZER | 28.00 | YR | F | Y | 61.22000 | KG | 20160928 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127890301 | 12789030 | 1 | PS | VENLAFAXINE HCL | VENLAFAXINE HYDROCHLORIDE | 1 | 150 MG, 1X/DAY | 20699 | 150 | MG | PROLONGED-RELEASE CAPSULE | QD | |||||||
| 127890301 | 12789030 | 2 | SS | VENLAFAXINE HCL | VENLAFAXINE HYDROCHLORIDE | 1 | 225 MG, 1X/DAY, 'THREE PILLS OF 75 MG' | 20699 | 225 | MG | PROLONGED-RELEASE CAPSULE | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127890301 | 12789030 | 1 | Bipolar disorder |
| 127890301 | 12789030 | 2 | Anxiety |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127890301 | 12789030 | Drug ineffective | |
| 127890301 | 12789030 | Dyspnoea | |
| 127890301 | 12789030 | Feeling abnormal | |
| 127890301 | 12789030 | Feeling jittery | |
| 127890301 | 12789030 | Pallor | |
| 127890301 | 12789030 | Tachycardia | |
| 127890301 | 12789030 | Tremor |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |